Agic Convertible & (NCV) 6.63 $NCV NCV, NCZ and ACV

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Agic Convertible & (NCV) 6.63 $NCV

NCV, NCZ and ACV Declare Monthly Distributions
BusinessWire - Mon Aug 01, 3:00PM CDT
--AllianzGI Convertible & Income Fund II
ACV: 18.74 (-0.23), NCZ: 5.65 (-0.15), NCV: 6.63 (-0.17)

AllianzGI Convertible & Income Fund Reports Results for the Fiscal Quarter Ended May 31, 2016
BusinessWire - Fri Jul 29, 3:00PM CDT
AllianzGI Convertible & Income Fund (the "Fund" (NYSE:NCV), a diversified closed-end management investment company which seeks to provide total return through a combination of capital appreciation and high current income, today announced its results for the fiscal quarter ended May 31, 2016.
NCV: 6.63 (-0.17)

Nicholas-Applegate Convertible & Income Fund Shares Up 31.1% Since SmarTrend's Buy Recommendation (NCV)
Comtex SmarTrend(R) - Fri Jul 29, 12:47AM CDT
SmarTrend identified an Uptrend for Nicholas-Applegate Convertible & Income Fund (NYSE:NCV) on March 4th, 2016 at $5.17. In approximately 5 months, Nicholas-Applegate Convertible & Income Fund has returned 31.14% as of today's recent price of $6.78.
NCV: 6.63 (-0.17)

Look for Shares of Nicholas-Applegate Convertible & Income Fund to Potentially Rebound after Yesterday's 1.87% Sell Off
Comtex SmarTrend(R) - Wed Jul 13, 4:16PM CDT
Nicholas-Applegate Convertible & Income Fund (NYSE:NCV) traded in a range yesterday that spanned from a low of $6.26 to a high of $6.45. Yesterday, the shares fell 1.9%, which took the trading range below the 3-day low of $6.29 on volume of 350,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
NCV: 6.63 (-0.17)

AllianzGI Convertible & Income Fund Reports Results for the Fiscal Quarter and Year Ended February 29, 2016
BusinessWire - Fri Apr 29, 3:00PM CDT
AllianzGI Convertible & Income Fund (the "Fund" (NYSE:NCV), a diversified closed-end management investment company which seeks to provide total return through a combination of capital appreciation and high current income, today announced its results for the fiscal quarter and year ended February 29, 2016.
NCV: 6.63 (-0.17)

Allianz Global Investors Fund Management Posts Revised Closed-End Fund Cards
BusinessWire - Fri Feb 05, 3:00PM CST
Allianz Global Investors Fund Management LLC (the "Investment Manager" announced today that revised Fund Cards, which contain statistical information on the funds listed below as of December 31, 2015, are now available at http://us.allianzgi.com/Literature/Pages/Clos...edEndFunds
NCZ: 5.65 (-0.15), NCV: 6.63 (-0.17)

Allianz Global Investors Fund Management Posts Updated Closed-End Fund Cards
BusinessWire - Fri Jan 29, 3:00PM CST
Allianz Global Investors Fund Management LLC (the "Investment Manager" announced today that Fund Cards, which contain statistical information on the funds listed below as of December 31, 2015, are now available at http://us.allianzgi.com/Literature/Pages/Clos...edEndFunds
NFJ: 12.55 (-0.10), ACV: 18.74 (-0.23), NCZ: 5.65 (-0.15), NIE: 19.08 (-0.12), NCV: 6.63 (-0.17)

AllianzGI Convertible & Income Fund Reports Results for the Fiscal Quarter and Nine Months Ended November 30, 2015
BusinessWire - Fri Jan 29, 3:00PM CST
AllianzGI Convertible & Income Fund (the "Fund" (NYSE:NCV), a diversified closed-end management investment company which seeks to provide total return through a combination of capital appreciation and high current income, today announced its results for the fiscal quarter and nine months ended November 30, 2015.
NCV: 6.63 (-0.17)

NCV, NCZ, and ACV Declare Monthly Common Share Income Dividends
BusinessWire - Tue Dec 01, 3:00PM CST
--AllianzGI Convertible & Income Fund II
ACV: 18.74 (-0.23), NCZ: 5.65 (-0.15), NCV: 6.63 (-0.17)

Shares of NCV Down 31.8% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Tue Nov 03, 10:25AM CST
SmarTrend identified a Downtrend for Nicholas-Applegate Convertible & Income Fund (NYSE:NCV) on September 30th, 2014 at $9.50. In approximately 13 months, Nicholas-Applegate Convertible & Income Fund has returned 31.75% as of today's recent price of $6.48.
NCV: 6.63 (-0.17)

AllianzGI Convertible & Income Fund Reports Results for the Fiscal Quarter and Six Months Ended August 31, 2015
BusinessWire - Fri Oct 30, 3:00PM CDT
AllianzGI Convertible & Income Fund (the "Fund" (NYSE:NCV), a diversified closed-end management investment company which seeks to provide total return through a combination of capital appreciation and high current income, today announced its results for the fiscal quarter and six months ended August 31, 2015.
NCV: 6.63 (-0.17)

Nicholas-Applegate Convertible & Income Fund Down 33.6% Since SmarTrend Downtrend Call (NCV)
Comtex SmarTrend(R) - Tue Oct 27, 9:29AM CDT
SmarTrend identified a Downtrend for Nicholas-Applegate Convertible & Income Fund (NYSE:NCV) on September 30th, 2014 at $9.50. In approximately 13 months, Nicholas-Applegate Convertible & Income Fund has returned 33.65% as of today's recent price of $6.30.
NCV: 6.63 (-0.17)

Nicholas-Applegate Convertible & Income Fund Shares Down 33.9% Since SmarTrend's Sell Call (NCV)
Comtex SmarTrend(R) - Mon Oct 19, 4:59PM CDT
SmarTrend identified a Downtrend for Nicholas-Applegate Convertible & Income Fund (NYSE:NCV) on September 30th, 2014 at $9.50. In approximately 13 months, Nicholas-Applegate Convertible & Income Fund has returned 33.86% as of today's recent price of $6.28.
NCV: 6.63 (-0.17)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CARsgen's CT1182 Data Opens a Careful New CAR-T Test

Updated Category News Views 126

Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 607

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
Cardiovalve's Three-Year Data Clears a Crucial EU Hurdle

Updated Category News Views 98

A failing tricuspid valve is not a spreadsheet problem, and that matters before anybody gets carried away with a glossy conference presentation. Venus Medtech's Cardiovalve unit has reported results from TARGET in a population that was old, sick and largely out of good surgical options. That is precisely where a less invasive replacement therapy has to prove it can do...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 731

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
UAE Ties Diplomacy, Media and AI Into a Shared Signal

Updated Category News Views 128

Influence is getting harder to measure, and easier to squander, which is why the message from Ajman deserves more than a polite nod. At the 2026 Ajman Media Forum, THE SIGNAL, Foreign Affairs Undersecretary Omar Obaid Alhesan Alshamsi made the UAE’s position plain: diplomacy and media are no longer separate lanes. Both operate on words, context, trust and the difficult...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 534

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 385

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 666

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
DataBeyond Puts AI Sorting Before a Waste Mountain

Updated Category News Views 191

Trash is a lousy place to look for technological glamour, which is precisely why DataBeyond's COP31 appearance deserves a sober look. On November 19 in Antalya, Türkiye, the Hangzhou-based equipment provider used a China Pavilion event to lay out its case for AI, optical sensing and robots in resource recovery. That is not a magic-green headline. It is a practical...

Continue Reading
Build-A-Bear Lawsuit Notice Carries a Date Problem

Updated Category News Views 26

Something is badly out of sequence in the Build-A-Bear shareholder alert, and that matters before anybody gets carried away by the legal boilerplate. The notice says investors who bought NYSE: BBW securities from March 28, 2026 through August 26, 2026 may be covered by a proposed federal securities class action. It also says the lead-plaintiff deadline is January 19,...

Continue Reading

Top 5 Most Recently Viewed Articles

NuCana Discontinues Phase 2 Colorectal Cancer Study

Updated Category News Views 146

NuCana Provides Update on Phase 2 Randomized Colorectal Cancer Study NuTide:323 Study Discontinued Following Initial Analysis Ongoing Studies Show Promise with NUC-7738 and Pembrolizumab NuCana plc (NASDAQ: NCNA) has shared important updates about its clinical trials focused on innovative treatments for colorectal cancer. The company has made the decision to discontinue...

Continue Reading
Brøndbyernes IF Football Meeting - Key Highlights Recap

Updated Category News Views 179

Overview of the Annual General Meeting for Brøndbyernes IF Football A/S BRØNDBYERNES I.F. FODBOLD A/S CVR-nr. 83 93 34 10 This report summarizes the outcomes of the annual general meeting conducted by Brøndbyernes IF Football A/S. Key Date and Location The annual shareholders meeting took place, gathering stakeholders and shareholders at the club's headquarters. A...

Continue Reading
Uncovering the Wealth from Investing in BlackRock

Updated Category News Views 314

The Potential Growth of $1000 in BlackRock Investors often wonder how their money would grow over time if invested in strong companies. Recently, we looked into BlackRock, Inc., known by its stock ticker BLK. Over a span of 15 years, investing just $1000 into BlackRock stocks would yield an impressive value today. According to current evaluations, if you had made that...

Continue Reading
Zealand Pharma Advances Glepaglutide Approval for SBS Treatment

Updated Category News Views 267

Glepaglutide Submission to EMA Marks Significant Progress Zealand Pharma A/S, a pioneering biotechnology company, has recently shared exciting news about its Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for its innovative drug, glepaglutide. This long-acting GLP-2 analog is specifically designed for treating adults suffering from short...

Continue Reading
Seven Gables Real Estate Partners with Local Logic for Insights

Updated Category News Views 40

Seven Gables Real Estate Partners with Local Logic In a significant move that underscores their dedication to innovation, Seven Gables Real Estate has announced an exciting partnership with Local Logic, a leader in location intelligence. This collaboration is set to incorporate Local Logic's cutting-edge products—Local Content, Local Search, and NeighborhoodWrap—into...

Continue Reading